Optimal Immunohistochemical Panel for Distinguishing Esophageal Adenocarcinoma from Squamous Cell Carcinoma

被引：0
|
作者：
DiMaio, M. A. [1 ]
Kwok, S. [1 ]
Montgomery, K. D. [1 ]
Lowe, A. W. [1 ]
Pai, R. K. [1 ]
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
来源：
MODERN PATHOLOGY | 2012年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
655
引用
收藏
页码：158A / 158A
页数：1
相关论文
共 50 条
  • [1] Optimal Immunohistochemical Panel for Distinguishing Esophageal Adenocarcinoma from Squamous Cell Carcinoma
    DiMaio, M. A.
    Kwok, S.
    Montgomery, K. D.
    Lowe, A. W.
    Pai, R. K.
    [J]. LABORATORY INVESTIGATION, 2012, 92 : 158A - 158A
  • [2] The role of immunohistochemical staining in distinguishing squamous cell carcinoma from mesothelioma and adenocarcinoma
    Tan, LC
    Bavikatty, N
    Michael, CW
    [J]. MODERN PATHOLOGY, 2002, 15 (01) : 88A - 88A
  • [3] Identification of immunohistochemical markers for distinguishing lung adenocarcinoma from squamous cell carcinoma
    Zhan, Cheng
    Yan, Li
    Wang, Lin
    Sun, Yang
    Wang, Xingxing
    Lin, Zongwu
    Zhang, Yongxing
    Shi, Yu
    Jiang, Wei
    Wang, Qun
    [J]. JOURNAL OF THORACIC DISEASE, 2015, 7 (08) : 1398 - +
  • [4] The role of immunohistochemical staining in distinguishing squamous cell carcinoma from mesothelioma and adenocarcinoma
    Tan, LC
    Bavikatty, N
    Michael, CW
    [J]. LABORATORY INVESTIGATION, 2002, 82 (01) : 88A - 88A
  • [5] Immunohistochemical panel for distinction between squamous cell carcinoma, adenocarcinoma and mesothelioma
    Pritchard, SA
    Howat, AJ
    Edwards, JM
    [J]. HISTOPATHOLOGY, 2003, 43 (02) : 197 - 199
  • [6] Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens
    Kim, Mi Jin
    Shin, Hyeong Chan
    Shin, Kyeong Cheol
    Rc, Jae Y.
    [J]. ANNALS OF DIAGNOSTIC PATHOLOGY, 2013, 17 (01) : 85 - 90
  • [7] Immunohistochemical panel for distinguishing esophageal adenocarcinoma from squamous cell carcinoma: a combination of p63, cytokeratin 5/6, MUC5AC, and anterior gradient homolog 2 allows optimal subtyping
    DiMaio, Michael A.
    Kwok, Shirley
    Montgomery, Kelli D.
    Lowe, Anson W.
    Pai, Reetesh K.
    [J]. HUMAN PATHOLOGY, 2012, 43 (11) : 1799 - 1807
  • [8] A prediction model for distinguishing lung squamous cell carcinoma from adenocarcinoma
    Li, Hui
    Jiang, Zhengran
    Leng, Qixin
    Bai, Fan
    Wang, Juan
    Ding, Xiaosong
    Li, Yuehong
    Zhang, Xianghong
    Fang, HongBin
    Yfantis, Harris G.
    Xing, Lingxiao
    Jiang, Feng
    [J]. ONCOTARGET, 2017, 8 (31) : 50704 - 50714
  • [9] A panel of biomarkers for esophageal squamous cell carcinoma
    Kashyap, Manoj K.
    Marimuthu, Arivusudar
    Kishore, C. J. H.
    Peri, Suraj
    Ranganathan, Prathibha
    Sanjeeviah, Ravinder C.
    Mahmood, Riaz
    Kumar, K. V. Veerendra
    Vijayakumar, M.
    Montgomery, Elizabeth
    Kumar, Rekha V.
    Pandey, Akhilesh
    [J]. FASEB JOURNAL, 2009, 23
  • [10] Genomic Variations in Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma
    Yasar, Hatime A.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
12345